Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ecnoglutide by Sciwind Biosciences for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Ecnoglutide is under clinical development by Sciwind Biosciences and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...
Ecnoglutide by Sciwind Biosciences for Type 2 Diabetes: Likelihood of Approval
Ecnoglutide is under clinical development by Sciwind Biosciences and currently in Phase II for Type 2 Diabetes. According to GlobalData,...
Ecnoglutide by Sciwind Biosciences for Obesity: Likelihood of Approval
Ecnoglutide is under clinical development by Sciwind Biosciences and currently in Phase II for Obesity. According to GlobalData, Phase II...